| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 924 | 987 | 951 | 1,525 | | Cost of Revenue | 1,099 | 1,070 | 624 | 1,238 | | | Gross Profit | (175) | (83) | 327 | 287 | | | Operating Expenses | | Research Development | 5,839 | 5,716 | 5,610 | 6,464 | | Selling General and Administrative | 3,283 | 3,667 | 3,814 | 4,036 | | Non Recurring |
-
|
-
|
-
| (5) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,297) | (9,466) | (9,097) | (10,208) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,209) | (908) | 243 | 347 | | Earnings Before Interest And Taxes | (11,506) | (10,374) | (8,854) | (9,861) | | Interest Expense | 19 | 20 | 11 | 12 | | Income Before Tax | (11,525) | (10,394) | (8,865) | (9,873) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,525) | (10,394) | (8,865) | (9,873) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,525) | (10,394) | (8,865) | (9,873) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,525) | ($10,394) | ($8,865) | ($9,873) |
|
0.51% Nasdaq 
0.02 (0.61%) 
Income Statement
